Schedule 13G ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: 2023-11-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-124715
- Form type
- SC 13G
- Filer
- Venrock Opportunities Fund, L.P.
- CIK
- CIK 1855405
- Filed
- Dec 08, 2023
- Reporting period
- Nov 01, 2023
- Description
- Schedule 13G beneficial ownership